Advertisement

Topics

Berkeley Lights, Bayer partner for cell line development and antibody discovery

03:42 EDT 14 Sep 2017 | Pharmaceutical Business Review

Berkeley Lights (BLI), a company dedicated to bringing to market transformational platforms for bio-pharmaceutical processes, has announced a strategic project with Bayer, focused on the innovation and acceleration of cell line development, antibody discovery, and research.

Original Article: Berkeley Lights, Bayer partner for cell line development and antibody discovery

NEXT ARTICLE

More From BioPortfolio on "Berkeley Lights, Bayer partner for cell line development and antibody discovery"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...